During Q4 2019, Avara’s Liscate facility hosted the US Food and Drug Administration (FDA) as part of a Pre-Approval Inspection for a new Client’s product to be manufactured in the Small Volume Parenterals department. A routine GMP inspection for the Lyophilization department was conducted. The FDA Inspector acknowledged the high standards and experience in Avara Liscate by recommending the renewal of the license and approval of the new product.
Additionally, Avara Liscate has announced the appointment of a new Manufacturing Director to the leadership team. Vincenzo Riello has joined Avara Liscate brings with him experience in sterile manufacturing gained over many years in large pharma organizations as well as CDMOs. Marco Scanziani, who held the position prior, will be Avara Liscate’s new Customer Relationship Leader and will apply his 15 years of manufacturing and quality experience to leading the Project Management function in Avara Liscate.